Advertisement

Related Videos

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Jan
27
Today In Oncology
Leader in Global Cancer Care, Paul E. Goss, MD, PhD, Dies at 70
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Pembrolizumab Plus Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma
Cabozantinib and Temozolomide in Unresectable or Metastatic Leiomyosarcoma
Nutrition Muscle Loss Compromises Survival in Patients With Cervical Cancer Undergoing Chemoradiotherapy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo